Record Details

Epidemiological features and financial loss due to clinically diagnosed Haemorrhagic septicemia in bovines in Karnataka, India

KRISHI: Publication and Data Inventory Repository

View Archive Info
 
 
Field Value
 
Title Epidemiological features and financial loss due to clinically diagnosed Haemorrhagic septicemia in bovines in Karnataka, India
Not Available
 
Creator Govindaraj G
Krishnamoorthy P
Nethrayini KR
Shalini R
Rahman H
 
Subject Haemorrhagic Septicemia Endemicity Mortality Morbidity Case fatality Financial loss
 
Description Not Available
The epidemiological features and financial losses due to Haemorrhagic Septicemia (HS) in bovines were
studied in Karnataka state using the primary data collected from 133 clinically diagnosed HS affected
farms. The various losses due to HS and the Benefit- Cost ofthe vaccination programme in cattle and water
buffaloes were studied using mathematical models. The number of HS outbreaks were higher during the
year 2002 and peaked during 2005 and thereafter declined due to targeted vaccination against HS. The
morbidity and mortality risks were lower in large farms than medium and small farms, and lower in
indigenous cattle compared to high yielding crossbred cattle and water buffaloes. The disease occurrence
was more in in-milk animals causing serious economic loss to the farmers. Most outbreaks were observed
during monsoon season, though the disease was prevalent throughout the year. The mean milk loss per
animal was $2, $11 and $50 in indigenous cattle, water buffaloes and crossbred cattle, respectively. In
the case of draught animals, the average effective draught power was unavailable for 1.2 days/outbreak
resulting in a loss of $5 per affected oxen. The treatment and extra labor expenses incurred per animal
were $24 and $7, respectively. The average loss per animal due to mortality loss was $275, $284 and $415
in case of indigenous cattle, water buffaloes and crossbred cattle, respectively. The projected loss for the
state of Karnataka were $23.89, $17.92 and $11.95 million under high, medium and low HS incidence
scenarios, respectively. The Benefit Cost Analysis (BCA) of the vaccination against HS has been estimated
at 5.97:1, 4.48:1 and 2.98:1 under high, medium and low incidence scenarios, respectively. The results
highlight the important epidemiological features and financial losses to the affected households and the
state of Karnataka.
Not Available
 
Date 2018-09-19T06:57:10Z
2018-09-19T06:57:10Z
2017-05-31
 
Type Research Paper
 
Identifier Not Available
0167-5877
http://krishi.icar.gov.in/jspui/handle/123456789/7001
 
Language English
 
Relation Not Available;
 
Publisher Elsevier Publications